Jessica Sanders

Jessica N. Sanders

Research Assistant Professor of Obstetrics and Gynecology and Adjunct Assistant Professor of Family and Preventive Medicine, University of Utah
Chapter Leader: Utah SSN

Connect with Jessica

About Jessica

Sanders’ expertise is in reproductive epidemiology, contraception and abortion. Her research focuses on issues of public health, obstetrics, and gynecology.

In the News

"Emergency Contraception Is Having Its Moment," Jessica N. Sanders, Rewire News Group, February 1, 2021.


"Two-Year Continuation of Intrauterine Devices and Contraceptive Impacts in a Mixed-Payer Setting: A Retrospective Review" (with David K. Turkok, Lori M. Gawron, Amy Law, Lonnie Wen, and Richard Lyen). American Journal of Obstetrics and Gynecology (2017).

Examines the proportion and characteristics of women who continue IUD and implant use to two years and relates continuation to device type when controlling for patient characteristics. 

"Perceived Barriers that Prevent High School Students Seeking Help from Teachers for Bullying and their Effects on Disclosure Intentions" (with Michael J. Boulton, Louise Boulton, James Down, and Helen Craddock). Journal of Adolescence 56 (2017): 40-51.

Investigated adolescent’s perceived barriers to disclosing bullying to teachers, included peer disapproval, feeling weak and a desire for autonomy.

"State-Mandated (Mis)Information and Women’s Endorsement of Common Abortion Myths " (with Heather Gould, Nancy F. Berglas, David K. Turok, and Alissa C. Perruci). Women’s Health Issues (2017): 1-7.

Examine women’s endorsement of common abortion myths before and after receiving state-mandated information that included accurate and inaccurate statements about abortion.

"Women's Sexual Function, Satisfaction, and Perceptions after Starting Long-Acting Reversible Contraceptives" (with David K. Turok, Mari Palta, and John Andrew Higgins). Obstetrics & Gynecology 128, no. 5 (2016): 1143-1151.

Explores the relationship between long-acting reversible contraception (LARC) and women’s sexual outcomes. New LARC users reported no measurable objective change in sexual function or satisfaction.